Deutsche Bank Ag\ Biogen Inc. Transaction History

Deutsche Bank Ag\

$240 Billion
Q3 2024

A detailed history of Deutsche Bank Ag\ transactions in Biogen Inc. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 714,285 shares of BIIB stock, worth $106 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

714,285

Previous 653,673 9.27%

Holding current value

$106 Million

Previous $152 Million 8.63%

% of portfolio

0.06%

Previous 0.07%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$189.07 - $236.8 $11.5 Million - $14.4 Million	60,612 Added 9.27%	714,285 $138 Million
Q2 2024 Aug 14, 2024	SELL	$190.52 - $236.72 $76.9 Million - $95.6 Million	-403,788 Reduced 38.18%	653,673 $152 Million
Q1 2024 May 15, 2024	SELL	$212.02 - $267.71 $28.1 Million - $35.5 Million	-132,429 Reduced 11.13%	1,057,461 $228 Million
Q4 2023 Feb 14, 2024	BUY	$222.59 - $267.94 $56.4 Million - $67.9 Million	253,408 Added 27.06%	1,189,890 $308 Million
Q3 2023 Nov 09, 2023	SELL	$253.3 - $285.89 $68.1 Million - $76.8 Million	-268,701 Reduced 22.3%	936,482 $241 Million
Q2 2023 Aug 14, 2023	SELL	$275.25 - $318.06 $120 Million - $139 Million	-436,565 Reduced 26.59%	1,205,183 $343 Million
Q1 2023 May 15, 2023	SELL	$256.56 - $292.34 $53.7 Million - $61.2 Million	-209,366 Reduced 11.31%	1,641,748 $456 Million
Q4 2022 Feb 13, 2023	BUY	$252.44 - $306.72 $62.5 Million - $76 Million	247,691 Added 15.45%	1,851,114 $513 Million
Q3 2022 Nov 14, 2022	SELL	$194.69 - $268.46 $12.4 Million - $17 Million	-63,476 Reduced 3.81%	1,603,423 $428 Million
Q2 2022 Aug 11, 2022	BUY	$187.54 - $223.02 $42.6 Million - $50.6 Million	227,008 Added 15.77%	1,666,899 $340 Million
Q1 2022 May 13, 2022	SELL	$193.77 - $244.14 $24.5 Million - $30.8 Million	-126,329 Reduced 8.07%	1,439,891 $303 Million
Q4 2021 Feb 11, 2022	BUY	$223.92 - $287.77 $41.4 Million - $53.2 Million	184,738 Added 13.37%	1,566,220 $376 Million
Q3 2021 Nov 04, 2021	SELL	$282.99 - $369.05 $9.54 Million - $12.4 Million	-33,712 Reduced 2.38%	1,381,482 $391 Million
Q2 2021 Aug 11, 2021	BUY	$259.0 - $414.71 $33.4 Million - $53.5 Million	128,955 Added 10.03%	1,415,194 $490 Million
Q1 2021 May 13, 2021	BUY	$242.95 - $284.63 $69.1 Million - $81 Million	284,571 Added 28.41%	1,286,239 $360 Million
Q4 2020 Feb 16, 2021	SELL	$236.26 - $355.63 $42.1 Million - $63.4 Million	-178,143 Reduced 15.1%	1,001,668 $245 Million
Q3 2020 Nov 12, 2020	BUY	$264.77 - $305.71 $44.8 Million - $51.7 Million	169,069 Added 16.73%	1,179,811 $335 Million
Q2 2020 Aug 13, 2020	SELL	$258.66 - $342.55 $15 Million - $19.8 Million	-57,942 Reduced 5.42%	1,010,742 $270 Million
Q1 2020 May 14, 2020	SELL	$268.85 - $341.04 $81.5 Million - $103 Million	-303,099 Reduced 22.1%	1,068,684 $338 Million
Q4 2019 Feb 14, 2020	SELL	$220.06 - $304.07 $92.8 Million - $128 Million	-421,690 Reduced 23.51%	1,371,783 $407 Million
Q3 2019 Nov 14, 2019	BUY	$217.44 - $243.88 $16.8 Million - $18.8 Million	77,240 Added 4.5%	1,793,473 $418 Million
Q2 2019 Aug 14, 2019	SELL	$219.29 - $241.72 $87.6 Million - $96.6 Million	-399,556 Reduced 18.88%	1,716,233 $401 Million
Q1 2019 May 15, 2019	BUY	$216.71 - $338.96 $189 Million - $296 Million	871,960 Added 70.1%	2,115,789 $500 Million
Q4 2018 Feb 14, 2019	SELL	$278.5 - $352.75 $118 Million - $149 Million	-423,325 Reduced 25.39%	1,243,829 $374 Million
Q3 2018 Dec 21, 2021	BUY	$293.51 - $383.83 $143 Million - $187 Million	486,948 Added 41.26%	1,667,154 $589 Million
Q3 2018 Nov 14, 2018	SELL	$293.51 - $383.83 $140 Million - $183 Million	-477,916 Reduced 28.82%	1,180,206 $417 Million
Q2 2018 Apr 21, 2020	BUY	$257.52 - $306.91 $75.7 Million - $90.2 Million	293,961 Added 21.55%	1,658,122 $481 Million
Q2 2018 Aug 14, 2018	SELL	$257.52 - $306.91 $555 Million - $661 Million	-2,154,056 Reduced 61.23%	1,364,161 $396 Million
Q1 2018 Oct 18, 2019	BUY	$260.13 - $367.91 $305 Million - $432 Million	1,173,505 Added 50.05%	3,518,217 $963 Million
Q1 2018 May 15, 2018	BUY	$260.13 - $367.91 $281 Million - $397 Million	1,080,054 Added 85.4%	2,344,712 $642 Million
Q4 2017 Feb 14, 2018	SELL	$307.64 - $344.58 $96 Million - $107 Million	-311,943 Reduced 19.79%	1,264,658 $403 Million
Q3 2017 Nov 14, 2017	BUY	$281.15 - $329.69 $443 Million - $520 Million	1,576,601	1,576,601 $494 Million

Others Institutions Holding BIIB

# of Institutions

1,037

Shares Held

126M

Call Options Held

1.13M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.5B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account